Endocrinology


Endocrinology Revenue Cycle Management Services

Manage Your Entire Practice On A Single Platform

With an affordable all in one solution for in-office and remote patient care. PracticeSuite provides flexible workflows to help organize your practice and keep it operating at peek efficiency; as well as a complete end to end virtual practice that allows you to treat any patient, anywhere, on any device.

Do you feel your in-house medical billing processes could be better?

ls it challenging to keep up with aging AR?

Need more staff or more expertise for your complex medical billing?

Over, 15,000 medical professionals from solo practitioners to large groups and medical centers rely on PracticeSuite’s cloud based medical billing technology to efficiently run their practice. Every feature required to run 150 different practice specialties is available but the system allows you to customize and simplify screens to see only what you want and need in each area of the software.

55a40bbd-0b91-43ae-852a-bc4d3730c791
or call

(510) 284-2425

We never share your information with anyone

In addition to an advanced billing system, PracticeSuite offers unparalleled Revenue Cycle Management features that stop revenue leaks before they occurs.

ICD-10 Endocrinology Superbill Example

Appointment Date & Time: Last Seen Date:
Patient: Gender: DOB: MR# Pat Due: INS Due:
Address: Reason:
Home Phone: Cell Phone: E-Mail:
Case Name: Case No: Case Type: Case Date:
Pr Insurance: Member ID: Co-Pay Amount: Deductible:
Rendering Provider: PCP: Referring Provider:
CPT CODES
CPT CodeDescriptionCPT CodeDescriptionCPT CodeDescription
78012Thyroid uptake, single or multiple quantitative measurement(s) (including stimulation, suppression or discharge, when performed))81506Endocrinology (type 2 diabetes), biochemical assays of seven analytes (glucose, HbA1C, insulin, hs-CRP, adoponectin, ferritin, interleukin 2-receptor alpha), utilizing serum or plasma, algorithm reporting a risk99489Complex chronic care coordination services; each additional 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (List separately in addition to code for primary procedure) (at present not paid by Medicare)
78012Thyroid uptake, single or multiple quantitative measurement(s) (including stimulation, suppression or discharge, when performed))90653Influenza vaccine, inactivated, subunit, adjuvanted, for IM use (FDA approval pending)99495Transitional Care Management Services with the following required elements:
Communication (direct contact, telephone, electronic) with patient and/or caregiver within 2 business days of discharge
Medical decision making of at least moderate complexity during the service period
Face-to-face visit, within 14 calendar days of discharge
78013Thyroid imaging (including vascular flow, when performed);90672Influenza virus vaccine, quadrivalent, live, for intranasal use99496Transitional Care Management Services with the following required elements:
Communication (direct contact, telephone, electronic) with patient and/or caregiver within 2 business days of discharge
Medical decision making of high complexity during the service period
Face-to-face visit, within 7 calendar days of discharge
78014Thyroid imaging (including vascular flow, when performed); with single or multiple uptake(s) quantitative measurement(s) (including stimulation, suppression, or discharge, when performed)90739Hepatitis B vaccine, adult dosage 92 dose schedule), for IM use (FDA approval pending)90655Influenza virus vaccine, trivalent, split virus, preservative free, when administered to children 6-35 months of age, for IM use
99488Complex chronic care coordination services; first hour of clinical staff time directed by a physician or other qualified health care professional with one face-to-face visit, per calendar month (at present not paid by Medicare)99487Complex chronic care coordination services; first hour of clinical staff time directed by a physician or other qualified health care professional with non-face-to-face visit, per calendar month (at present not paid by Medicare)90656Influenza virus vaccine, trivalent, split virus, preservative free, when administered to individuals 3 years and older, for IM use
90657Influenza virus vaccine, trivalent, split virus, when administered to children 6-35 months of age, for IM use5100F(Potential risk for fracture communicated to the referring physician or other qualified health care professional within 24 hours of completion of the imaging  study76536Ultrasound, soft tissues of head and neck
(e.g. thyroid, parathyroid, parotid), real time
with image documentation
90658Influenza virus vaccine, trivalent, split virus, when administered to individuals 3 years of age and older, for IM use76536Ultrasound, soft tissues of head and neck
(e.g. thyroid, parathyroid, parotid), real time
with image documentation
60100Biopsy, thyroid, percutaneous core needle
90660Influenza virus vaccine, trivalent, live for intranasal use76942Ultrasonic guidance for needle placement
(e.g., biopsy, aspiration, injection, localization
device), imaging supervision and interpretation
10022Fine needle aspiration; with imaging guidance
90746Hepatitis B vaccine, adult dosage (3 does schedule), for IM use10022Fine needle aspiration; with imaging guidance76942Ultrasonic guidance for needle placement
(e.g., biopsy, aspiration, injection, localization
device), imaging supervision and interpretation
5010F(Findings of dilated macular or fundus exam communicated to the physician or other qualified health care professional managing the diabetes care)60100Biopsy, thyroid, percutaneous core needle99203Consult
76536Thyroid ultrasound76942Ultrasonic guidance for needle biopsy77080, 77081Bone densitometry DXA
ICD CODES
ICD-10 Description ICD-10 Description ICD-10 Description
C37 Malignant neoplasm of thymus D44.10 Neoplasm of uncertain behavior of unspecified adrenal gland E08.9 Diabetes mellitus due to underlying condition without complications
C56.1 Malignant neoplasm of right ovary D44.11 Neoplasm of uncertain behavior of right adrenal gland E09.9 Drug or chemical induced diabetes mellitus without complications
C56.2 Malignant neoplasm of left ovary D44.12 Neoplasm of uncertain behavior of left adrenal gland E13.9 Other specified diabetes mellitus without complications
C56.9 Malignant neoplasm of unspecified ovary D44.0 Neoplasm of uncertain behavior of thyroid gland E08.10 Diabetes mellitus due to underlying condition with ketoacidosis without coma
C73 Malignant neoplasm of thyroid gland D44.2 Neoplasm of uncertain behavior of parathyroid gland E09.10 Drug or chemical induced diabetes mellitus with ketoacidosis without coma
C74.00 Malignant neoplasm of cortex of unspecified adrenal gland D44.8 Neoplasm of uncertain behavior with pluriglandular involvement E13.10 Other specified diabetes mellitus with ketoacidosis without coma
C74.01 Malignant neoplasm of cortex of right adrenal gland E04.0 Nontoxic diffuse goiter E08.01 Diabetes mellitus due to underlying condition with hyperosmolarity with coma
C74.02 Malignant neoplasm of cortex of left adrenal gland E01.0 Iodine-deficiency related diffuse (endemic) goiter E09.00 Drug or chemical induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic- hyperosmolar coma (NKHHC)
C74.10 Malignant neoplasm of medulla of unspecified adrenal gland E01.1 Iodine-deficiency related multinodular (endemic) goiter E09.01 Drug or chemical induced diabetes mellitus with hyperosmolarity with coma
C74.11 Malignant neoplasm of medulla of right adrenal gland E01.2 Iodine-deficiency related (endemic) goiter, unspecified E13.00 Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic- hyperosmolar coma (NKHHC)
C74.12 Malignant neoplasm of medulla of left adrenal gland E04.0 Nontoxic diffuse goiter E13.01 Other specified diabetes mellitus with hyperosmolarity with coma
C74.90 Malignant neoplasm of unspecified part of unspecified adrenal gland E04.9 Nontoxic goiter, unspecified E08.11 Diabetes mellitus due to underlying condition with ketoacidosis with coma
C74.91 Malignant neoplasm of unspecified part of right adrenal gland E04.1 Nontoxic single thyroid nodule E08.641 Diabetes mellitus due to underlying condition with hypoglycemia with coma
C74.92 Malignant neoplasm of unspecified part of left adrenal gland E01.1 Iodine-deficiency related multinodular (endemic) goiter E09.11 Drug or chemical induced diabetes mellitus with ketoacidosis with coma
C75.0 Malignant neoplasm of parathyroid gland E04.2 Nontoxic multinodular goiter E09.641 Drug or chemical induced diabetes mellitus with hypoglycemia with coma
C75.1 Malignant neoplasm of pituitary gland E05.00 Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm E13.11 Other specified diabetes mellitus with ketoacidosis with coma
C75.2 Malignant neoplasm of craniopharyngeal duct E05.01 Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm E13.641 Other specified diabetes mellitus with hypoglycemia with coma
C75.5 Malignant neoplasm of aortic body and other paraganglia E05.10 Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm E11.9 Type 2 diabetes mellitus without complications
C79.70 Secondary malignant neoplasm of unspecified adrenal gland E05.20 Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm E10.9 Type 1 diabetes mellitus without complications
C79.71 Secondary malignant neoplasm of right adrenal gland E05.90 Thyrotoxicosis, unspecified without thyrotoxic crisis or storm E10.10 Type 1 diabetes mellitus with ketoacidosis without coma
C79.72 Secondary malignant neoplasm of left adrenal gland E05.91 Thyrotoxicosis, unspecified with thyrotoxic crisis or storm E10.11 Type 1 diabetes mellitus with ketoacidosis with coma
D13.6 Benign neoplasm of pancreas E89.0 Postprocedural hypothyroidism E11.00 Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
D27.0 Benign neoplasm of right ovary E89.0 Postprocedural hypothyroidism E11.01 Type 2 diabetes mellitus with hyperosmolarity with coma
D27.1 Benign neoplasm of left ovary E03.2 Hypothyroidism due to medicaments and other exogenous substances E10.11 Type 1 diabetes mellitus with ketoacidosis with coma
D27.9 Benign neoplasm of unspecified ovary E01.8 Other iodine-deficiency related thyroid disorders and allied conditions E10.641 Type 1 diabetes mellitus with hypoglycemia with coma
D29.20 Benign neoplasm of unspecified testis E02 Subclinical iodine-deficiency hypothyroidism E11.21 Type 2 diabetes mellitus with diabetic nephropathy
D29.21 Benign neoplasm of right testis E03.3 Postinfectious hypothyroidism E11.22 Type 2 diabetes mellitus with diabetic chronic kidney disease
D29.22 Benign neoplasm of left testis E03.8 Other specified hypothyroidism E11.29 Type 2 diabetes mellitus with other diabetic kidney complication
D34 Benign neoplasm of thyroid gland E03.9 Hypothyroidism, unspecified E10.21 Type 1 diabetes mellitus with diabetic nephropathy
D35.00 Benign neoplasm of unspecified adrenal gland E06.0 Acute thyroiditis E10.22 Type 1 diabetes mellitus with diabetic chronic kidney disease
D35.01 Benign neoplasm of right adrenal gland E06.3 Autoimmune thyroiditis E10.29 Type 1 diabetes mellitus with other diabetic kidney complication
D35.02 Benign neoplasm of left adrenal gland E06.5 Other chronic thyroiditis E11.311 Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema
D35.1 Benign neoplasm of parathyroid gland E06.4 Drug-induced thyroiditis E11.319 Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema
D35.2 Benign neoplasm of pituitary gland E04.1 Nontoxic single thyroid nodule E11.321 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema
D35.3 Benign neoplasm of craniopharyngeal duct Z80.43 Family history of malignant neoplasm of testis E11.329 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema
D35.4 Benign neoplasm of pineal gland Z83.3 Family history of diabetes mellitus E11.331 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema
D44.3 Neoplasm of uncertain behavior of pituitary gland Z83.41 Family history of multiple endocrine neoplasia [MEN] syndrome E11.339 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema
E21.1 Secondary hyperparathyroidism, not elsewhere classified E34.0 Carcinoid syndrome E11.351 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema
E20.0 Idiopathic hypoparathyroidism E34.2 Ectopic hormone secretion, not elsewhere classified E11.359 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema
E20.8 Other hypoparathyroidism E34.3 Short stature due to endocrine disorder E11.36 Type 2 diabetes mellitus with diabetic cataract
E20.9 Hypoparathyroidism, unspecified E34.50 Androgen insensitivity syndrome, unspecified E11.39 Type 2 diabetes mellitus with other diabetic ophthalmic complication
E89.2 Postprocedural hypoparathyroidism E30.8 Other disorders of puberty E10.40 Type 1 diabetes mellitus with diabetic neuropathy, unspecified
E22.0 Acromegaly and pituitary gigantism E34.1 Other hypersecretion of intestinal hormones E10.41 Type 1 diabetes mellitus with diabetic mononeuropathy
E34.4 Constitutional tall stature E34.8 Other specified endocrine disorders E10.42 Type 1 diabetes mellitus with diabetic polyneuropathy
E22.1 Hyperprolactinemia E35 Disorders of endocrine glands in diseases classified elsewhere E10.43 Type 1 diabetes mellitus with diabetic autonomic (poly) neuropathy
E22.8 Other hyperfunction of pituitary gland E08.311 Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema E10.44 Type 1 diabetes mellitus with diabetic amyotrophy
E22.9 Hyperfunction of pituitary gland, unspecified E08.319 Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema E10.49 Type 1 diabetes mellitus with other diabetic neurological complication
E23.0 Hypopituitarism E09.311 Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema E10.610 Type 1 diabetes mellitus with diabetic neuropathic arthropathy
E23.2 Diabetes insipidus E09.319 Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy without macular edema E11.51 Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene
E23.1 Drug-induced hypopituitarism E10.311 Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema E11.52 Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene
E89.3 Postprocedural hypopituitarism E10.319 Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema E11.59 Type 2 diabetes mellitus with other circulatory complications
E32.8 Other diseases of thymus E11.311 Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema E10.618 Type 1 diabetes mellitus with other diabetic arthropathy
E24.0 Pituitary-dependent Cushing’s disease E11.319 Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema E10.620 Type 1 diabetes mellitus with diabetic dermatitis
E24.2 Drug-induced Cushing’s syndrome E13.311 Other specified diabetes mellitus with unspecified diabetic retinopathy with macular edema E10.621 Type 1 diabetes mellitus with foot ulcer
E24.3 Ectopic ACTH syndrome E13.319 Other specified diabetes mellitus with unspecified diabetic retinopathy without macular edema E10.622 Type 1 diabetes mellitus with other skin ulcer
E24.4 Alcohol-induced pseudo-Cushing’s syndrome E08.351 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema E10.628 Type 1 diabetes mellitus with other skin complications
E24.8 Other Cushing’s syndrome E08.359 Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema E10.630 Type 1 diabetes mellitus with periodontal disease
E24.9 Cushing’s syndrome, unspecified E09.351 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema E10.638 Type 1 diabetes mellitus with other oral complications
E26.09 Other primary hyperaldosteronism E09.359 Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema E10.649 Type 1 diabetes mellitus with hypoglycemia without coma
E26.9 Hyperaldosteronism, unspecified E10.351 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema E10.65 Type 1 diabetes mellitus with hyperglycemia
E27.0 Other adrenocortical overactivity E10.359 Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema E10.69 Type 1 diabetes mellitus with other specified complication
E27.1 Primary adrenocortical insufficiency E11.351 Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema E15 Nondiabetic hypoglycemic coma
E27.2 Addisonian crisis E11.359 Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema E16.2 Hypoglycemia, unspecified
E27.3 Drug-induced adrenocortical insufficiency E13.351 Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema E89.1 Postprocedural hypoinsulinemia
E27.40 Unspecified adrenocortical insufficiency E13.359 Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema E16.3 Increased secretion of glucagon
E27.49 Other adrenocortical insufficiency E09.339 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema E21.3 Hyperparathyroidism, unspecified
E89.6 Postprocedural adrenocortical (-medullary) hypofunction Z80.41 Family history of malignant neoplasm of ovary E21.0 Primary hyperparathyroidism
E27.40 Unspecified adrenocortical insufficiency E10.321 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema E10.341 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema
E27.49 Other adrenocortical insufficiency E10.329 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema E10.349 Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema
E28.0 Estrogen excess E11.321 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema E11.341 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema
E89.40 Asymptomatic postprocedural ovarian failure E11.329 Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema E11.349 Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema
E89.41 Symptomatic postprocedural ovarian failure E13.321 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema E13.341 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema
E28.310 Symptomatic premature menopause E13.329 Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema E13.349 Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema
E28.319 Asymptomatic premature menopause E08.321 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema E08.341 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema
E28.39 Other primary ovarian failure E08.329 Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema E08.349 Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema
E28.2 Polycystic ovarian syndrome E09.321 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema E09.341 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema
E29.0 Testicular hypofunction E09.329 Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema E09.349 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema
E89.5 Postprocedural testicular hypofunction E10.331 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema E09.36 Drug or chemical induced diabetes mellitus with diabetic cataract
E29.1 Testicular hyperfunction E10.339 Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema E10.36 Type 1 diabetes mellitus with diabetic cataract
E31.21 Multiple endocrine neoplasia [MEN] type I E11.331 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema E11.36 Type 2 diabetes mellitus with diabetic cataract
E31.22 Multiple endocrine neoplasia [MEN] type IIA E11.339 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema E13.36 Other specified diabetes mellitus with diabetic cataract
E31.23 Multiple endocrine neoplasia [MEN] type IIB E13.331 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema E08.36 Diabetes mellitus due to underlying condition with diabetic cataract
E31.9 Polyglandular dysfunction, unspecified E13.339 Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema R73.09 Other abnormal glucose
E30.0 Delayed puberty E08.331 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema R73.9 Hyperglycemia, unspecified
E30.1 Precocious puberty E08.339 Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema Z85.43 Personal history of malignant neoplasm of ovary
E30.8 Other disorders of puberty E09.331 Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema Z85.47 Personal history of malignant neoplasm of testis
Charges:     CASH Doctor’s Signature
Payments:     CHECK:
    MC AMX
Balance:     VISA DEBT
Credit Card#

Start Billing
Just Seconds From Now!